Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Corvus Pharmaceuticals, Inc
Scientific Title
A Phase 1/1b Multicenter Study To Evaluate The Humanized Anti-CD73 Antibody, CPI-006, As A Single Agent, In Combination With CPI-444, And In Combination With Pembrolizumab In Adult Subjects With Advanced Cancers